These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29799933)

  • 21. Core Concepts Involving Adverse Psychotropic Drug Effects: Assessment, Implications, and Management.
    Goldberg JF; Ernst CL
    Psychiatr Clin North Am; 2016 Sep; 39(3):375-89. PubMed ID: 27514295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.
    Drozda K; Müller DJ; Bishop JR
    Pharmacotherapy; 2014 Feb; 34(2):166-84. PubMed ID: 24523097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics of psychotropic drug response.
    Malhotra AK; Murphy GM; Kennedy JL
    Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicians' opinions following pharmacogenetic testing for psychotropic medication.
    Walden LM; Brandl EJ; Changasi A; Sturgess JE; Soibel A; Notario JF; Cheema S; Braganza N; Marshe VS; Freeman N; Tiwari AK; Kennedy JL; Müller DJ
    Psychiatry Res; 2015 Oct; 229(3):913-8. PubMed ID: 26298505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outliers on the dose-response curve: how to minimize this problem using therapeutic drug monitoring, an underutilized tool in psychiatry.
    Preskorn SH
    J Psychiatr Pract; 2010 May; 16(3):177-82. PubMed ID: 20485106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacogenetics and prediction of side effects of drugs].
    Harrak M; Khabbal Y; Amarti A; El Hassouni M; Ouldim K
    Ann Biol Clin (Paris); 2014; 72(4):405-12. PubMed ID: 25119798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Providing patients with information on pharmacogenetic testing.
    Fleeman N; Dickson R
    Nurs Stand; 2009 Jan 28-Feb 3; 23(21):46-8. PubMed ID: 19248450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine program.
    Reynolds KK; Pierce DL; Weitendorf F; Linder MW
    Per Med; 2017 May; 14(3):221-233. PubMed ID: 29767587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opening Pandora's box in the UK: a hypothetical pharmacogenetic test for clozapine.
    Spencer BW; Prainsack B; Rujescu D; Giegling I; Collier DA; Gaughran F; MacCabe JH; Barr CL; Sigurdsson E; Stovring H; Malhotra AK; Curran SR;
    Pharmacogenomics; 2013 Nov; 14(15):1907-14. PubMed ID: 24236489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetic Testing: Why Is It So Disappointing?
    Limandri BJ
    J Psychosoc Nurs Ment Health Serv; 2019 Apr; 57(4):9-12. PubMed ID: 30933297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetic testing in the United Kingdom genetics and immunogenetics laboratories.
    Higgs J; Gambhir N; Ramsden SC; Poulton K; Newman WG
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):121-5. PubMed ID: 20039783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Utility and Economic Impact of CYP2D6 Genotyping.
    Reynolds KK; McNally BA; Linder MW
    Clin Lab Med; 2016 Sep; 36(3):525-42. PubMed ID: 27514466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetic aspects in the metabolism of psychotropic drugs: pharmacokinetic and clinical implications.
    Spina E; Caputi AP
    Pharmacol Res; 1994; 29(2):121-37. PubMed ID: 8058586
    [No Abstract]   [Full Text] [Related]  

  • 34. Facilitating clinical implementation of pharmacogenomics.
    Mrazek DA; Lerman C
    JAMA; 2011 Jul; 306(3):304-5. PubMed ID: 21771991
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry].
    Stephan PL; Etzensberger M; Jaquenoud Sirot E
    Praxis (Bern 1994); 2006 Apr; 95(17):671-8. PubMed ID: 16686323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression: a case report.
    Antoniazzi S; Tatulli A; Falvella FS; Cigliobianco M; Paoli RA; Cattaneo D; Cheli S; Bernardi FF; Clementi E; Altamura CA
    J Clin Pharm Ther; 2017 Feb; 42(1):119-121. PubMed ID: 27800629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of delivery strategies for pharmacogenetic testing services.
    Haga SB; Moaddeb J
    Pharmacogenet Genomics; 2014 Mar; 24(3):139-45. PubMed ID: 24384556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of pharmacogenetics in psychiatry].
    Skrętkowicz J; Barańska M; Rychlik-Sych M
    Wiad Lek; 2013; 66(2 Pt 2):185-91. PubMed ID: 25775815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress and prospects in pharmacogenetics of antidepressant drugs.
    Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.